1-12 of 12
NamPhuong Tran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study

Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans C. Lee, Vaishali Sanchorawala, Peter Mollee, Jin Lu, Stefan Schönland, Moshe E Gatt, Kenshi Suzuki, Kihyun Kim, M. Teresa Cibeira, Manisha Bhutani, Meral Beksac, Edward Libby, Jason Valent, Vania Hungria, Michael Rosenzweig, Naresh Bumma, Antoine Huart, NamPhuong Tran, Jianping Wang, Yuping Chen, Sandra Y. Vasey, Jordan M. Schecter, Jessica Vermeulen, Raymond L. Comenzo, Giampaolo Merlini
Journal: Blood
Blood (2024) 144 (Supplement 1): 891.
https://doi.org/10.1182/blood-2024-205077
Published: 2024
Journal Articles

Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in a Diverse Patient Population with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius

Michael Rosenzweig, Yvonne Efebera, Efstathios Kastritis, Brandon Blue, Faizi Jamal, Monique C Minnema, Christopher Pericone, Sandra Vasey, Yuping Chen, Sonja Kotoulek, Bart Vandael, Joana Duran, Samer Khaled, NamPhuong Tran, Jessica Vermeulen, Vaishali Sanchorawala
Journal: Blood
Blood (2023) 142 (Supplement 1): 4785.
https://doi.org/10.1182/blood-2023-181953
Published: 2023
Journal Articles

Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in Patients with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius

Vaishali Sanchorawala, Michael Rosenzweig, Christopher Pericone, Sandra Y. Vasey, Xiang Qin, Sonja Marie Kotoulek, Bart Vandael, Joana Duran, Samer Khaled, NamPhuong Tran, Efstathios Kastritis
Journal: Blood
Blood (2022) 140 (Supplement 1): 10163–10164.
https://doi.org/10.1182/blood-2022-163615
Published: 2022
Journal Articles

Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study

Meletios A. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tobias Kampfenkel, Weiping Liu, Michele Kosh, NamPhuong Tran, Robin Carson, Pieter Sonneveld
Journal: Blood
Blood (2022) 140 (Supplement 1): 7272–7274.
https://doi.org/10.1182/blood-2022-163483
Published: 2022
Journal Articles

Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study

Raymond Comenzo, Giovanni Palladini, Efstathios Kastritis, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Angela Dispenzieri, Hans C. Lee, Vaishali Sanchorawala, Simon D. Gibbs, Peter Mollee, Chris P. Venner, Jin Lu, Stefan Schönland, Moshe Gatt, Kenshi Suzuki, Kihyun Kim, M. Teresa Cibeira, Meral Beksac, Edward Libby, Jason Valent, Vania Hungria, Sandy W. Wong, Michael Rosenzweig, Naresh Bumma, NamPhuong Tran, Xiang Qin, Samer Khaled, Jessica Vermeulen, Giampaolo Merlini
Journal: Blood
Blood (2021) 138 (Supplement 1): 159.
https://doi.org/10.1182/blood-2021-146820
Published: 2021
Journal Articles

Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study

Pieter Sonneveld, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tobias Kampfenkel, Yanping Qiu, Himal Amin, Michele Kosh, NamPhuong Tran, Robin Carson, Meletios A. Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2747.
https://doi.org/10.1182/blood-2021-146907
Published: 2021
Journal Articles

Rapid and Deep Hematologic Responses Are Associated with Improved Major Organ Deterioration Progression-Free Survival in Newly Diagnosed AL Amyloidosis: Results from Andromeda

Ashutosh D. Wechalekar, MD, Giovanni Palladini, MD PhD, Giampaolo Merlini, MD, Raymond L. Comenzo, MD, Arnaud Jaccard, MD PhD, NamPhuong Tran, MD, Huiling Pei, PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Efstathios Kastritis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-140514
Published: 2020
Journal Articles

Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda

Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Giovanni Palladini, MD PhD, Monique C. Minnema, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM, Arnaud Jaccard, MD PhD, Vaishali Sanchorawala, MD, Hans C. Lee, MD, Simon D. Gibbs, FRACP, FRCPA, MBBS, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Christopher P. Venner, MD, Jin Lu, Stefan Schönland, MD, Moshe Gatt, MD, Kenshi Suzuki, MD PhD, Kihyun Kim, MD PhD, M. Teresa Cibeira, MD PhD, Meral Beksac, MD, Edward Libby, MD, Jason Valent, MD, Vania T. M. Hungria, MD PhD, Sandy W. Wong, MD, Michael Rosenzweig, MD, Naresh Bumma, MD, Dominique Chauveau, MD PhD, Meletios A Dimopoulos, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Giampaolo Merlini, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–50.
https://doi.org/10.1182/blood-2020-137582
Published: 2020
Journal Articles

Outcomes By Cardiac Stage in Newly Diagnosed AL Amyloidosis: Results from Andromeda

Monique C. Minnema, Angela Dispenzieri, MD, Giampaolo Merlini, MD, Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM, Martha Grogan, MD, Ronald Witteles, MD, Frederick L. Ruberg, MD, Mathew S. Maurer, MD, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Arnaud Jaccard, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-139754
Published: 2020
Journal Articles

Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study

Kenshi Suzuki, MD PhD, Ashutosh D. Wechalekar, Kihyun Kim, MD, Chihiro Shimazaki, MD PhD, Jin Seok Kim, MD PhD, Takayuki Ikezoe, MD PhD, Chang-Ki Min, MD, PhD, Fude Zhou, Shinsuke Iida, MD PhD, Nagaaki Katoh, Tomoaki Fujisaki, MD, Ho-Jin Shin, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Jin Lu
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-136150
Published: 2020
Journal Articles

Health-Related Quality of Life in Patients with AL Amyloidosis Treated with Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone: Results from the Phase 3 Andromeda Study

Vaishali Sanchorawala, MD, Giovanni Palladini, MD PhD, Monique C. Minnema, Arnaud Jaccard, MD PhD, Hans C. Lee, MD, Simon D. Gibbs, FRACP, FRCPA, MBBS, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Christopher P. Venner, MD, Jin Lu, Stefan Schönland, MD, Moshe Gatt, MD, Kenshi Suzuki, MD PhD, Kihyun Kim, MD, M. Teresa Cibeira, MD PhD, Meral Beksac, MD, Edward Libby, MD, Jason Valent, MD, Vania T. M. Hungria, MD PhD, Sandy W. Wong, MD, Michael Rosenzweig, MD, Naresh Bumma, MD, Dominique Chauveau, MD PhD, Katharine S. Gries, PhD PharmD, John Fastenau, RPh, MPH, PhD, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Giampaolo Merlini, MD, Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–40.
https://doi.org/10.1182/blood-2020-139438
Published: 2020
Journal Articles

Administration of a CD31-Derived Peptide Delays the Onset and Significantly Increases Survival From Lethal Graft-Versus-Host Disease

Yanfei Chen, Paul G. Schlegel, Namphuong Tran, Diana Thompson, James L. Zehnder, Nelson J. Chao
Journal: Blood
Blood (1997) 89 (4): 1452–1459.
https://doi.org/10.1182/blood.V89.4.1452
Published: 1997